Drugs / ABT-450/r/ABT-267
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01939197 | Aug 2013 → Jul 2016 | HIV infectious disease, chronic hepatitis C virus infection | AbbVie | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT-450/r/ABT-267 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01939197 ↗ |